Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > New Partnership with Teen Cancer America
View:
Post by Jonnyboy85 on Nov 11, 2021 9:49am

New Partnership with Teen Cancer America

StageZero and TCA plan several initiatives, including:

  • A combined educational campaign aimed at generating awareness around the challenges faced by adolescents and young adults with cancer and the need to improve screening and treatment.
  • Dissemination of TCA's soon to be published health economic research that reveals the true cost of cancer for young people, health systems, and society.
  • Stage Zero's clinical studies to validate their Aristotle® technology in the early detection of testicular, brain, and colorectal cancers in adolescents and young adults.
Comment by Jonnyboy85 on Nov 11, 2021 9:50am
https://teencanceramerica.org/
Comment by RelevantStock on Nov 11, 2021 2:57pm
Awesome find, thanks Jonny. If we reach 0.35 in the next days we could start a daily reversal. I am neutral on the earnings, but CA revenue combined with unexpected covid testing revenu could surprise. Bolta
StageZero Life Sciences Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities